Suppr超能文献

下丘脑和神经垂体中血管加压素含量的异常并非自发性高血压大鼠高血压的结果。

Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat.

作者信息

Sladek C D, Devine M A, Felten S Y, Aravich P F, Blair M L

机构信息

Department of Neurology, University of Rochester School of Medicine, NY 14642.

出版信息

Brain Res. 1988 Mar 29;445(1):39-46. doi: 10.1016/0006-8993(88)91071-2.

Abstract

In order to determine if the decreased hypothalamic and increased posterior pituitary content of vasopressin (VP) observed previously in spontaneously hypertensive rats (SHR) were a secondary consequence of the hypertension, the effect of preventing the development of hypertension on VP content of the hypothalamoneurohypophyseal system was evaluated. Two methods for preventing the hypertension were used: (1) chronic angiotensin-converting enzyme inhibition (oral captopril, 100 mg/kg/day at 4-12 weeks of age); and (2) intraventricular 6-hydroxydopamine (6-OHDA, 200 micrograms at 4 and 5 weeks of age). Both of these treatments markedly attenuated the increase in systolic blood pressure in SHRs at 5-11 weeks of age. The captopril-treated rats had a significant elevation in serum renin activity at 12 weeks of age indicating the presence of chronic converting enzyme inhibition, and the 6-OHDA-treatment resulted in a depletion of hypothalamic (86%) and brainstem (76%) norepinephrine content. Hypothalamic VP content was reduced in untreated SHRs compared to normotensive Wistar-Kyoto rats (WKYs, P = 0.0015). It was not significantly altered in either strain by the 6-OHDA treatment. Captopril caused a reduction in hypothalamic VP content in both SHRs and WKYs (P less than 0.01). Posterior pituitary VP content was elevated in untreated SHRs compared to WKYs (P less than 0.001), and remained elevated with captopril and 6-OHDA treatments. These data indicate that the abnormalities in VP content in the hypothalamus and posterior pituitary of SHRs are not a response to the hypertension. Therefore, they may represent primary abnormalities in the SHR.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了确定先前在自发性高血压大鼠(SHR)中观察到的下丘脑血管加压素(VP)含量降低和垂体后叶VP含量增加是否是高血压的继发后果,评估了预防高血压发展对下丘脑神经垂体系统VP含量的影响。采用了两种预防高血压的方法:(1)慢性血管紧张素转换酶抑制(口服卡托普利,100mg/kg/天,在4至12周龄时);(2)脑室内注射6-羟基多巴胺(6-OHDA,200μg,在4和5周龄时)。这两种治疗方法均显著减轻了5至11周龄SHR收缩压的升高。卡托普利治疗的大鼠在12周龄时血清肾素活性显著升高,表明存在慢性转换酶抑制,而6-OHDA治疗导致下丘脑(86%)和脑干(76%)去甲肾上腺素含量耗竭。与正常血压的Wistar-Kyoto大鼠(WKY)相比,未治疗的SHR下丘脑VP含量降低(P = 0.0015)。6-OHDA治疗在两种品系中均未使其显著改变。卡托普利导致SHR和WKY下丘脑VP含量均降低(P < 0.01)。与WKY相比,未治疗的SHR垂体后叶VP含量升高(P < 0.001),并且在卡托普利和6-OHDA治疗后仍保持升高。这些数据表明,SHR下丘脑和垂体后叶VP含量的异常不是对高血压的反应。因此,它们可能代表SHR的原发性异常。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验